Employing tumor hypoxia to enhance oncolytic viral therapy in breast cancer
- 31 August 2004
- Vol. 136 (2) , 199-204
- https://doi.org/10.1016/j.surg.2004.04.016
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Hypoxia and estrogen receptor profile influence the responsiveness of human breast cancer cells to estradiol and antiestrogensCellular and Molecular Life Sciences, 2004
- Origin and Evolution of Viral Interleukin-10 and Other DNA Virus Genes with Vertebrate HomologuesJournal of Molecular Evolution, 2002
- Generation of bidirectional hypoxia/HIF-responsive expression vectors to target gene expression to hypoxic cellsGene Therapy, 2001
- Cytokine Gene Transfer Enhances Herpes Oncolytic Therapy in Murine Squamous Cell CarcinomaHuman Gene Therapy, 2001
- Conditionally replicating herpes simplex virus mutant, G207 for the treatment of malignant glioma: results of a phase I trialGene Therapy, 2000
- Development of a hypoxia-responsive vector for tumor-specific gene therapyGene Therapy, 2000
- Treatment of Human Breast Cancer in a Brain Metastatic Model by G207, a Replication-Competent Multimutated Herpes Simplex Virus 1Human Gene Therapy, 1998
- Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomasNature Medicine, 1995
- Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension.Proceedings of the National Academy of Sciences, 1995
- Reduction of RibonucleotidesAnnual Review of Biochemistry, 1979